Staurosporine-induced G1 arrest is associated with the induction and accumulation of cyclin-dependent kinase inhibitors

Cell Growth and Differentiation

Volumn 7, Issue 10, 1996, Pages 1305-1313

  Kwon, Taeg Kyu ^a   Buchholz, Meredith A ^a   Chrest, Francis J ^a   Nordin, Albert A ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; PROTEIN KINASE INHIBITOR; STAUROSPORINE; CYCLINE; ENZYME INHIBITOR; RETINOBLASTOMA PROTEIN;

ARTICLE; CANCER GROWTH; CELL CYCLE G1 PHASE; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; BREAST TUMOR; CELL CULTURE; CELL DIVISION; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; METABOLISM; PATHOLOGY;

BREAST NEOPLASMS; CELL DIVISION; CYCLIN-DEPENDENT KINASES; CYCLINS; ENZYME INHIBITORS; FEMALE; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; RETINOBLASTOMA PROTEIN; STAUROSPORINE; TUMOR CELLS, CULTURED;

EID: 0030254187     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. 2 block caused by staurosporine. Exp. Cell Res., 192: 122-127, 1991.
2. 1 phase of the cell cycle. Proc. Natl. Acad. Sci. USA, 88: 7580-7584, 1991.
3. 1 phase of nontransformed mammalian cells are absent in transformed cells. Proc. Natl. Acad. Sci. USA, 89: 8626-8630, 1992.
4. Tamaoki, T. Use and specificity of staurosporine. UCN-01 and calphostin C as protein kinase inhibitors. Methods Enzymol., 201:340-347, 1991.
5. Gadbois, D. M., Hamaguchi, J. R., Swank, R. A., and Bradbury, E. M. Staurosporine is a potent inhibitor of p34 cdc2 and p34 cdc2-like kinase. Biochem. Biophys. Res. Commun., 184: 80-85, 1992.
6. 1 arrest of a human lung epithelial cell line by staurosporine. J. Cell. Physiol., 152: 646-653, 1992.
7. Pines, J. Cyclins and cyclin-dependent kinases: take your partners. Trends Biochem. Sci., 18: 195-197, 1993.
8. 1 cyclins. Cell, 73: 1059-1065, 1993.
9. Norbury, C., and Nurse, P. Animal cell cycles and their control. Annu. Rev. Biochem., 61: 441-470, 1992.
10. Hunter, T., and Pines, J. Cyclins and cancer. II. Cyclin D and CDK inhibitors come of age. Cell, 79: 573-582, 1994.
11. Morgan, D. O. Principles of CDK regulation. Nature (Lond.), 374: 131-134, 1995.
12. 1 cyclin-dependent kinases. Genes Dev., 9: 1149-1163, 1995.
13. Weinberg, R. A. The retinoblastoma protein and cell cycle control. Cell, 81: 323-330, 1995.
14. Lees, J. A., Buchkovich, K. J., Marshak, D. R., Anderson, C. W., and Harlow, E. The retinoblastoma protein is phosphorylated on multiple sites by human cdc2. EMBO J., 10: 4279-4290, 1991.
15. Akiyama, T., Ohuchi, T., Sumida, S., Matsumoto, K., and Toyoshima, K. Phosphorylation of the retinoblastoma protein by cdk2. Proc. Natl. Acad. Sci. USA, 89: 7900-7904, 1992.
16. Ewer, M. E., Sluss, H. K., Whitehouse, L. L., and Livingston, D. M. TGFb inhibition of cdk4 synthesis is linked to cell cycle arrest. Cell, 74: 1009-1200, 1993.
17. Helin, K., Lees, J. A., Vidal, M., Dyson, N., Harlow, E., and Fattaey, A. A. cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell, 70: 337-350, 1992.
18. Krek, W., Ewen, M. E., Shirodkar, S., Arany, Z., Kaelin Jr., W. G., and Livingston, D. M. Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell, 78 161-172, 1994.
19. 1 between the cyclin D and cyclin E restriction points. Cancer Res., 54: 3136-3139, 1994.
20. 1 arrest at two points: Effect on retinoblastoma protein phosphorylation and cyclin-dependent kinase 2 in normal and transformed cells. Cancer Res., 54: 5959-5963, 1994.
21. El-Deiry, W. S., Tokino T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, E., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
22. Serrano, M., Hannon, G. J., and Beach, D. A new regulatory motif in the cell cycle control causing specific inhibition of cyclin D/cdk4. Nature (Lond.), 366: 704-707, 1993.
23. INK4b is a potential effector of cell cycle arrest mediated by TGF-β. Nature (Lond.), 371: 257-261, 1994.
24. INK4/MTS2- related cdk6 inhibitor, correlates with wide type pRb function. Genes Dev., 8: 2939-2952, 1994.
25. Ink4) in human breast carcinomas. Cancer Res., 54: 5262-5264, 1994.
26. Kip1, a cyclin-cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev., 8: 9-22, 1994.
27. Firpo, E. J., Koff, A., Solomon, M. J., and Roberts, J. M. Inactivation of a cdk2 inhibitor during interteukin 2-induced proliferation of human T lymphocytes. Mol. Cell. Biol., 14: 4889-4901, 1994.
28. Hengst, L., Dulic, V., Slingerland, J. M., Lees, E., and Reed, S. I. A cell cycle-regulated inhibitor of cyclin-dependent kinases. Proc. Natl. Acad. Sci. USA, 91: 5291-5295, 1994.
29. Poon, R. Y. C., Toyoshima, H., and Hunter, T. Redistribution of the cdk inhibitor p27 between different cyclin.cdk complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation. Mol. Biol. Cell, 6: 1197-1213, 1995.
30. Kip1) of cyclin-dependent kinase 4 activation. Cell, 79: 487-496, 1994.
31. Aprelikova, O., Xing, Y., and Liu, E. T. Both p16 and p21 families of cyclin-dependent kinase (CDK) inhibitors block the phosphorylation of cyclin-dependent kinases by the CDK-activating kinase. J. Biol. Chem., 270: 18195-18197, 1995.
32. Bruno, S., Ardelt, B., Skierski, J. S., Traganos, F., and Darzynkiewicz, Z. Different effects of staurosporine, an inhibitor of protein kinases, on the cell cycle and chromatin structure of normal and leukemic lymphocytes. Cancer Res., 52: 470-473, 1992.
33. Zhang, H., Hannon, G. T., and Beach, D. p21-containing cyclin kinases exist in both active and inactive states. Genes Dev., 8: 1750-1758, 1994.
34. Jeoung, D. I., Tang, B., and Sonenberg, M. Induction of tumor suppressor p21 protein by kinase inhibitors in MCF-7 cells. Biochem. Biophys. Res. Commun., 214: 361-366, 1995.
35. 1 phase progression: cycling on cue. Cell, 79: 551-556, 1994.
36. Heichman, K. A., and Roberts, J. M. Rules to replicate by. Cell, 79: 557-562, 1994.
37. Kip1 for restriction point control of the fibroblast cell cycle. Science (Washington DC), 272: 877-880, 1996.
38. 1 cyclin/cdk protein kinase activity, is related to p21. Cell, 78: 67-74, 1994.
39. Kip1. Gene, in press, 1996.
40. Kip display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell, 85: 707-720, 1996.
41. Kip. Cell, 85: 721-732, 1996.
42. Kip-deficient mice. Cell, 85: 733-744, 1996.
43. Kaufman, S. H., and Shaper, J. H. Erasure of western blots after autoradiography or chemiluminescent detection. Appl. Biochem. Biotechnol., 38: 243-255, 1993.
44. Maniatis, T., Fritsch, E. F., and Sambrook, J. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
45. Kim, Y. H., Proust, J. J., Buchholz, M. J., Chrest, F. J., and Nordin, A. A. Expression of the murine homologue of the cell cycle control protein p34 cdc2 in T lymphocytes. J. Immunol., 149: 17-23, 1992.